EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Bioorthogonal Chemistry: An Emerging Strategy for Targeted Protein Degradation

Pijun Zhou, Junda Li, Jinyi Xu, Yansong Ren, Shengtao Xu iD

Chemistry – A European Journal · 2026

DOI: 10.1002/chem.202502876 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemistry – A European Journal, 2026. Verfasst von Pijun Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Prodrugs, Proteins, Small Molecule Libraries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 143 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted protein degradation (TPD) technologies represent a promising strategy to overcome drug resistance associated with traditional small‐molecule inhibitors (SMIs) while targeting traditionally considered nondruggable targets. However, the frequent noncompliance of TPD agents with Lipinski's “Rule of Five” poses significant druggability challenges. Off‐target toxicity and the “hook effect” further limit TPD applications. With the development of bioorthogonal chemistry, self‐assembly TPD agents and TPD agent prodrugs based on bioorthogonal chemistry offer a viable solution to address these issues. This review summarizes recent advances in integrating bioorthogonal chemistry with TPD technologies, specifically highlighting its role in improving conventional TPD agents drawbacks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsProteinsSmall Molecule LibrariesHumansProteolysis

Stichwörter der Autor:innen

bioorthogonal chemistryprodrugsself‐assemblytargeted protein degradation (TPD)

Substanzen

ProdrugsProteinsSmall Molecule Libraries

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.

ORCID-Profile: Shengtao Xu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhou, P., Li, J., Xu, J., Ren, Y., & Xu, S. (2026). Bioorthogonal Chemistry: An Emerging Strategy for Targeted Protein Degradation. Chemistry – A European Journal. https://doi.org/10.1002/chem.202502876

Vancouver

Zhou P, Li J, Xu J, Ren Y, Xu S. Bioorthogonal Chemistry: An Emerging Strategy for Targeted Protein Degradation. Chemistry – A European Journal. 2026. doi:10.1002/chem.202502876

BibTeX
@article{Zhou2026,
  author = {Zhou, Pijun and Li, Junda and Xu, Jinyi and Ren, Yansong and Xu, Shengtao},
  title = {Bioorthogonal Chemistry: An Emerging Strategy for Targeted Protein Degradation},
  journal = {Chemistry – A European Journal},
  year = {2026},
  doi = {10.1002/chem.202502876}
}
Kostenlos starten →